TMED6
gene geneOn this page
Also known as MGC23911p24gamma5p24g5
Summary
TMED6 (transmembrane p24 trafficking protein 6, HGNC:28331) is a protein-coding gene on chromosome 16q22.1, encoding Transmembrane emp24 domain-containing protein 6 (Q8WW62).
Predicted to be involved in Golgi organization; endoplasmic reticulum to Golgi vesicle-mediated transport; and intracellular protein transport. Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in several cellular components, including COPII-coated ER to Golgi transport vesicle; Golgi apparatus; and endoplasmic reticulum-Golgi intermediate compartment.
Source: NCBI Gene 146456 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 47 total
- MANE Select transcript:
NM_144676
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28331 |
| Approved symbol | TMED6 |
| Name | transmembrane p24 trafficking protein 6 |
| Location | 16q22.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC23911, p24gamma5, p24g5 |
| Ensembl gene | ENSG00000157315 |
| Ensembl biotype | protein_coding |
| Entrez | 146456 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 retained_intron
ENST00000288025, ENST00000568748, ENST00000905348
RefSeq mRNA: 1 — MANE Select: NM_144676
NM_144676
CCDS: CCDS10878
Canonical transcript exons
ENST00000288025 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001141377 | 69343250 | 69343640 |
| ENSE00001141383 | 69351541 | 69351786 |
| ENSE00003589572 | 69347788 | 69347936 |
| ENSE00003619228 | 69349525 | 69349651 |
Expression profiles
Bgee: expression breadth ubiquitous, 169 present calls, max score 97.22.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.3744 / max 379.0775, expressed in 34 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 157902 | 0.3744 | 34 |
Top tissues by expression
255 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 97.22 | gold quality |
| right uterine tube | UBERON:0001302 | 95.09 | gold quality |
| pancreas | UBERON:0001264 | 94.10 | gold quality |
| islet of Langerhans | UBERON:0000006 | 92.49 | gold quality |
| body of stomach | UBERON:0001161 | 86.74 | gold quality |
| stomach | UBERON:0000945 | 83.84 | gold quality |
| duodenum | UBERON:0002114 | 82.31 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 82.17 | gold quality |
| fundus of stomach | UBERON:0001160 | 80.33 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 80.11 | gold quality |
| kidney epithelium | UBERON:0004819 | 79.62 | silver quality |
| rectum | UBERON:0001052 | 79.35 | gold quality |
| oviduct epithelium | UBERON:0004804 | 79.04 | gold quality |
| cardia of stomach | UBERON:0001162 | 77.65 | gold quality |
| fallopian tube | UBERON:0003889 | 77.11 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 75.34 | gold quality |
| ileal mucosa | UBERON:0000331 | 74.01 | silver quality |
| right lobe of liver | UBERON:0001114 | 73.39 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 71.62 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 70.95 | gold quality |
| small intestine | UBERON:0002108 | 70.85 | gold quality |
| cortex of kidney | UBERON:0001225 | 70.37 | gold quality |
| transverse colon | UBERON:0001157 | 70.30 | gold quality |
| granulocyte | CL:0000094 | 69.97 | gold quality |
| kidney | UBERON:0002113 | 69.66 | gold quality |
| colonic mucosa | UBERON:0000317 | 69.46 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 68.83 | gold quality |
| leukocyte | CL:0000738 | 68.47 | gold quality |
| monocyte | CL:0000576 | 68.37 | gold quality |
| liver | UBERON:0002107 | 68.36 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 18.96 |
| E-GEOD-81608 | yes | 4.42 |
| E-GEOD-83139 | yes | 4.01 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
17 targeting TMED6, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-137-3P | 99.87 | 74.74 | 2401 |
| HSA-MIR-323A-3P | 99.79 | 70.30 | 1739 |
| HSA-MIR-320A-3P | 99.77 | 69.73 | 2107 |
| HSA-MIR-320B | 99.77 | 69.73 | 2107 |
| HSA-MIR-320C | 99.77 | 69.73 | 2107 |
| HSA-MIR-320D | 99.77 | 69.73 | 2107 |
| HSA-MIR-4429 | 99.77 | 69.62 | 2111 |
| HSA-MIR-6885-3P | 99.75 | 70.36 | 3187 |
| HSA-MIR-1208 | 99.70 | 68.28 | 1533 |
| HSA-MIR-4646-3P | 98.65 | 66.98 | 693 |
| HSA-MIR-3944-5P | 98.50 | 67.55 | 997 |
| HSA-MIR-4771 | 97.43 | 67.69 | 596 |
| HSA-MIR-4433B-5P | 95.91 | 66.56 | 727 |
| HSA-MIR-4323 | 93.93 | 63.89 | 656 |
Literature-anchored findings (GeneRIF, showing 1)
- TMED6-COG8 chimera might act as a novel diagnostic marker in TFE3 translocation renal cell carcinoma. (PMID:26045774)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmed6 | ENSDARG00000088079 |
| mus_musculus | Tmed6 | ENSMUSG00000031919 |
| rattus_norvegicus | Tmed6 | ENSRNOG00000020406 |
| drosophila_melanogaster | loj | FBGN0061492 |
| caenorhabditis_elegans | WBGENE00011606 |
Paralogs (8): TMED2 (ENSG00000086598), TMED1 (ENSG00000099203), TMED5 (ENSG00000117500), TMED7 (ENSG00000134970), TMED4 (ENSG00000158604), TMED3 (ENSG00000166557), TMED10 (ENSG00000170348), TMED9 (ENSG00000184840)
Protein
Protein identifiers
Transmembrane emp24 domain-containing protein 6 — Q8WW62 (reviewed: Q8WW62)
Alternative names: p24 family protein gamma-5
All UniProt accessions (1): Q8WW62
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Endoplasmic reticulum membrane.
Similarity. Belongs to the EMP24/GP25L family.
RefSeq proteins (1): NP_653277* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009038 | GOLD_dom | Domain |
| IPR015720 | Emp24-like | Family |
Pfam: PF01105
UniProt features (9 total): topological domain 2, glycosylation site 2, signal peptide 1, chain 1, transmembrane region 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WW62-F1 | 82.13 | 0.56 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 107, 156
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 50 (showing top):
GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN, chr16q22, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, GOBP_VESICLE_MEDIATED_TRANSPORT, HNF1_Q6, GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT, GOCC_COATED_VESICLE, SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, HNF1_C, HNF1_01, VECCHI_GASTRIC_CANCER_EARLY_DN, GOBP_GOLGI_ORGANIZATION, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT
GO Biological Process (3): intracellular protein transport (GO:0006886), endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888), Golgi organization (GO:0007030)
GO Molecular Function (0):
GO Cellular Component (6): endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), endoplasmic reticulum-Golgi intermediate compartment (GO:0005793), Golgi apparatus (GO:0005794), COPII-coated ER to Golgi transport vesicle (GO:0030134), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 4 |
| intracellular membrane-bounded organelle | 3 |
| intracellular transport | 2 |
| endomembrane system | 2 |
| intracellular protein localization | 1 |
| protein transport | 1 |
| intercellular transport | 1 |
| Golgi vesicle transport | 1 |
| organelle organization | 1 |
| endomembrane system organization | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| coated vesicle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
548 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMED6 | COG8 | Q96MW5 | 651 |
| TMED6 | A0A3B3ITX9 | A0A3B3ITX9 | 593 |
| TMED6 | F8VZ95 | F8VZ95 | 578 |
| TMED6 | TMED7 | Q9Y3B3 | 551 |
| TMED6 | TMED9 | Q9BVK6 | 542 |
| TMED6 | LARGE2 | Q8N3Y3 | 500 |
| TMED6 | TMED10 | P49755 | 499 |
| TMED6 | TMED2 | Q15363 | 493 |
| TMED6 | TTC7B | Q86TV6 | 493 |
| TMED6 | CEP76 | Q8TAP6 | 492 |
| TMED6 | COPZ2 | Q9P299 | 491 |
| TMED6 | IQCF6 | A8MYZ5 | 481 |
| TMED6 | TMEM132A | Q24JP5 | 478 |
| TMED6 | TMED3 | Q9Y3Q3 | 478 |
| TMED6 | NIP7 | Q9Y221 | 467 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMED6 | SMPD2 | psi-mi:“MI:0914”(association) | 0.530 |
| TMED6 | UPK3BL1 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC35A2 | PRSS2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (59): ALG9 (Affinity Capture-MS), SMPD2 (Affinity Capture-MS), VEZT (Affinity Capture-MS), LRP12 (Affinity Capture-MS), ATP2A3 (Affinity Capture-MS), ITGA2 (Affinity Capture-MS), C1QL1 (Affinity Capture-MS), BTN2A2 (Affinity Capture-MS), CNTNAP3B (Affinity Capture-MS), CNNM1 (Affinity Capture-MS), B4GALNT1 (Affinity Capture-MS), CGRRF1 (Affinity Capture-MS), KCNJ8 (Affinity Capture-MS), FUT10 (Affinity Capture-MS), NETO2 (Affinity Capture-MS)
ESM2 similar proteins: B3MTS8, B3NZM5, B4GMC3, B4HJV5, B4JG34, B4KB41, B4LYB8, B4NKL0, B4PVC6, B4QWH9, F4J4Y0, O35587, O43909, P0CN72, P24387, P24388, P49755, Q0VCA9, Q14849, Q28557, Q28735, Q295B2, Q3T133, Q4WQL0, Q5B5L5, Q5E971, Q5I0E7, Q5RE32, Q5ZLK8, Q60571, Q63584, Q6AY64, Q6IDL4, Q6NZZ3, Q7Z7H5, Q8GYG1, Q8R1V4, Q8RWM6, Q8WW62, Q91653
Diamond homologs: Q0VCA9, Q8WW62, Q9CQG0
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
47 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 37 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
772 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:69347884:T:C | acceptor_gain | 1.0000 |
| 16:69351538:TA:T | donor_loss | 1.0000 |
| 16:69351539:A:AG | donor_loss | 1.0000 |
| 16:69351539:A:C | donor_loss | 1.0000 |
| 16:69351540:C:CT | donor_loss | 1.0000 |
| 16:69351540:CCT:C | donor_gain | 1.0000 |
| 16:69351547:A:C | donor_gain | 1.0000 |
| 16:69351539:A:AC | donor_gain | 0.9900 |
| 16:69351540:C:CC | donor_gain | 0.9900 |
| 16:69351601:T:TA | donor_gain | 0.9900 |
| 16:69343405:G:C | donor_gain | 0.9800 |
| 16:69343636:CCGTC:C | acceptor_gain | 0.9600 |
| 16:69343637:CGTCC:C | acceptor_gain | 0.9600 |
| 16:69343638:GTCC:G | acceptor_loss | 0.9600 |
| 16:69343640:CCTA:C | acceptor_loss | 0.9600 |
| 16:69343641:C:CC | acceptor_gain | 0.9600 |
| 16:69343641:CT:C | acceptor_loss | 0.9600 |
| 16:69347884:T:TC | acceptor_gain | 0.9600 |
| 16:69351598:G:A | donor_gain | 0.9600 |
| 16:69343637:CGTC:C | acceptor_gain | 0.9400 |
| 16:69347883:CT:C | acceptor_gain | 0.9400 |
| 16:69347884:TT:T | acceptor_gain | 0.9400 |
| 16:69349691:CA:C | donor_gain | 0.9300 |
| 16:69351540:CCTCG:C | donor_gain | 0.9000 |
| 16:69349727:T:TA | donor_gain | 0.8900 |
| 16:69351536:CATA:C | donor_gain | 0.8900 |
| 16:69351542:TCGTA:T | donor_gain | 0.8800 |
| 16:69351735:C:CT | acceptor_gain | 0.8800 |
| 16:69351735:C:T | acceptor_gain | 0.8800 |
| 16:69343603:A:C | acceptor_gain | 0.8500 |
AlphaMissense
1592 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:69343503:G:C | S209R | 0.994 |
| 16:69343503:G:T | S209R | 0.994 |
| 16:69343505:T:G | S209R | 0.994 |
| 16:69347921:C:G | C119S | 0.979 |
| 16:69347922:A:T | C119S | 0.979 |
| 16:69351590:C:G | C55S | 0.979 |
| 16:69351591:A:T | C55S | 0.979 |
| 16:69347876:A:G | L134P | 0.974 |
| 16:69351591:A:G | C55R | 0.973 |
| 16:69347924:A:G | L118P | 0.970 |
| 16:69343579:C:G | R184P | 0.969 |
| 16:69343517:A:G | S205P | 0.965 |
| 16:69343484:C:G | G216R | 0.963 |
| 16:69343484:C:T | G216R | 0.963 |
| 16:69347931:A:C | Y116D | 0.958 |
| 16:69343520:A:G | W204R | 0.957 |
| 16:69343520:A:T | W204R | 0.957 |
| 16:69351546:A:C | Y70D | 0.956 |
| 16:69347932:A:C | F115L | 0.955 |
| 16:69347932:A:T | F115L | 0.955 |
| 16:69347934:A:G | F115L | 0.955 |
| 16:69343483:C:T | G216E | 0.953 |
| 16:69351622:A:C | F44L | 0.953 |
| 16:69351622:A:T | F44L | 0.953 |
| 16:69351624:A:G | F44L | 0.953 |
| 16:69347918:A:G | L120P | 0.952 |
| 16:69343597:C:G | R178P | 0.951 |
| 16:69351589:G:C | C55W | 0.950 |
| 16:69347922:A:G | C119R | 0.949 |
| 16:69347882:A:T | V132E | 0.947 |
dbSNP variants (sampled 300 via entrez): RS1000113971 (16:69344995 A>G), RS1000464612 (16:69344676 G>A,C), RS1000571616 (16:69349164 T>C), RS1000799614 (16:69348530 G>T), RS1000952872 (16:69343156 T>C), RS1001305903 (16:69349760 G>C,T), RS1002064463 (16:69349624 C>A,G), RS1002114621 (16:69343243 T>C,G), RS1002308382 (16:69348508 G>T), RS1002359429 (16:69348673 T>TG), RS1002583776 (16:69342922 C>T), RS1002732951 (16:69352628 C>G,T), RS1002784655 (16:69345661 C>A,G,T), RS1002916815 (16:69353239 G>A), RS1003315029 (16:69347260 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_13 | Body mass index | 5.000000e-11 |
| GCST007006_16 | Logical memory (delayed recall) in normal cognition | 7.000000e-07 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0004874 | memory performance |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects expression, decreases expression | 4 |
| Cyclosporine | decreases expression, increases expression | 3 |
| aristolochic acid I | increases expression | 1 |
| dicrotophos | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| jinfukang | decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Lead | decreases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Quercetin | decreases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.